CT-Defined Osteosarcopenia Is Associated with Mortality in Metastatic Prostate Cancer: A Longitudinal Analysis of Opportunistic CT Imaging
Journal of Clinical Medicine · 30.10.2026 · 15 (21) · 8453
DOI: 10.3390/jcm15218453 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 30.10.2026. Verfasst von Tayler D Ross und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Orthopaedic Surgery, University of Toronto, 149 College Street, Toronto, ON M5T 1P5, Canada. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institutes of Health Research, Hold’em for Life Charity, University of Toronto.
Abstract (Originalsprache)
Background/Objectives: In metastatic prostate cancer, loss of bone density (osteoporosis), muscle quantity and quality (sarcopenia) may contribute to fractures, falls, and mortality. Unfortunately, their longitudinal assessment is poorly characterized. In prostate cancer, ageing, advanced disease, and cancer treatments may accelerate bone and muscle loss. This study assessed longitudinal computed tomography-derived musculoskeletal biomarkers in metastatic prostate cancer and the association between baseline osteosarcopenia and mortality.
Methods
This retrospective single-centre cohort included 437 patients, 3595 muscle computed tomography (CT) assessments and 2944 bone CT assessments. An automated deep-learning pipeline quantified lumbar trabecular bone mineral density (BMD), psoas muscle volume (PV), and psoas muscle density. Osteosarcopenia was defined as concurrent osteoporosis (BMD < 135 Hounsfield Units (HU)) and sarcopenia (volumetric psoas muscle index (vPMI) < 30). Patient-aware mixed-effects models characterized biomarker trends and reverse-time analysis. Kaplan–Meier analysis and Cox proportional-hazards regressions were utilized to assess mortality.
Results
Baseline osteosarcopenia affected 75 patients (17.2%). Psoas density decreased by 1.569 HU/year (95% confidence interval (CI) −1.703 to −1.434 HU/yr). Nonlinear models estimated mean declines in psoas volume (−6.42 cm3/year) and bone density (−6.01 HU/year). Among deceased patients, modelled final-year declines showed −12.57% in psoas density and −10.28% in psoas volume. Baseline osteosarcopenia was associated with higher all-cause mortality (Hazard Ratio (HR) 1.611; 95% CI 1.134–2.288; p = 0.008).
Conclusions
Osteosarcopenia is common and progressive in metastatic prostate cancer, and muscle loss accelerates near death. Baseline osteosarcopenia independently identifies patients at increased mortality risk. CT imaging provides a scalable approach for longitudinal assessment of musculoskeletal health and offers clinically important information without additional patient burden.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Orthopaedic Surgery, University of Toronto, 149 College Street, Toronto, ON M5T 1P5, Canada.
- Institute of Medical Science, Temerty Faculty of Medicine, University of Toronto, C. David Naylor Building, 6 Queen's Park Crescent, Toronto, ON M5S 3H2, Canada.
- Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, ON M4N 3M5, Canada.
- Institute of Biomedical Engineering, University of Toronto, 164 College Street, Toronto, ON M5S 3G9, Canada.
- Temerty School of Medicine, Temerty Faculty of Medicine, University of Toronto, 1 King's College Circle, Toronto, ON M5S 1A8, Canada.
- Odette Cancer Centre, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, ON M4N 3M5, Canada.
ORCID-Profile: Tayler D Ross, Saleh Tabatabaei, Urban Emmenegger, Michael Hardisty
Förderung
- Canadian Institutes of Health Research
- Hold’em for Life Charity
- University of Toronto
- SCACE Graduate Fellowship in Prostate Cancer Research
- Comprehensive Research Experience for Medical Students Summer Research Program
Zitieren
APA
Ross, T. D., Tabatabaei, S., Yakubov, R., Emmenegger, U., Whyne, C., & Hardisty, M. (2026). CT-Defined Osteosarcopenia Is Associated with Mortality in Metastatic Prostate Cancer: A Longitudinal Analysis of Opportunistic CT Imaging. Journal of Clinical Medicine, 15(21), 8453. https://doi.org/10.3390/jcm15218453
Vancouver
Ross TD, Tabatabaei S, Yakubov R, Emmenegger U, Whyne C, Hardisty M. CT-Defined Osteosarcopenia Is Associated with Mortality in Metastatic Prostate Cancer: A Longitudinal Analysis of Opportunistic CT Imaging. Journal of Clinical Medicine. 2026;15(21):8453. doi:10.3390/jcm15218453
BibTeX
@article{Ross2026,
author = {Ross, Tayler D and Tabatabaei, Saleh and Yakubov, Rose and Emmenegger, Urban and Whyne, Cari and Hardisty, Michael},
title = {CT-Defined Osteosarcopenia Is Associated with Mortality in Metastatic Prostate Cancer: A Longitudinal Analysis of Opportunistic CT Imaging},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {21},
pages = {8453},
doi = {10.3390/jcm15218453}
}
EUVIMED